Insight 20223
August 31 – September 3 in Berlin
Buy Tickets

Ketamine-augmented psychotherapy for depression (KAP) – A treatment approach for outpatient practice.

  • 09/09/2021
  • 10:00 - 12:30
  • August Bier room (5th floor)


In Germany more than 4 million people suffer from depression (WHO 2017). Ketamine, which was initially developed as anaesthetic is now also used in the tratment of depression. Different from classic antidepressants as SSRI’s, which show effects only after some weeks of treatment, with the use of Ketamine you can see a fast-acting antidepressant effect already some hours after intake. Many patients experience a short lasting altered state of consciousness during their Ketamine-intake. So far this was seen as a side-effect of the therapy with Ketamine. In Ketamine-augmented psychotherapy (KAP) these altered states of consciousness are therapeutically used and embedded in a specifically designed psychotherapy. The KAP prepares patients for and helps in the integration of experiences made in altered states of consciousness. This opens a new therapeutic window for a change of perception, emotions and behaviour in everyday life.

In this workshop, we will give you elementary information about Ketamine-augmented psychotherapy and the integration of experiences made in altered states of consciousness. We will give you an insight into the work of psychotherapists and medical doctors at the OVID-Health practice, where we offer KAP as a new approach in the therapy of mental disorders. For a lively impression we will provide you with case-reports from our practice. Additionally, we want to invite you to make your own experience in an altered state of consciousness by offering you a guided breathwork session. We will discuss these
experiences and answer your questions about our treatment offer at OVID Health practice.

Materials to bring with you to the workshop:

  • pillow
  • yoga mat
  • blanket
  • If you cannot bring any of these materials with you, please contact the facilitators via [email protected]

Related Events

Dipl.-Psych. Max Leidenberger Dr. rer. medic. Laura F. Kuhle Dr. rer. nat. Barbara Breitenstein, Dipl.-Psych.

Mehr als vier Millionen Menschen in Deutschland leiden unter einer Depression und viele von ihnen erleben, dass bisherige Therapien nicht immer ausreichend geholfen haben. Für diese Menschen stell

Dr. med. Sebastian Gaus

We present the clinical case of a 53 years‐old woman who underwent ketamine‐assisted psychotherapy in OVID practice due to depressive symptoms developed over the course of one year. These sympt

Anthena Blak

To fully explore the positive neurological and psychoactive effects of a ketamine augmented psychotherapy (KAP) treatment, patients’ voices must be heard. To understand my perception and experien

Go to Top